First Citizens Bank & Trust CO Dynavax Technologies Corp Transaction History
First Citizens Bank & Trust CO
- $5.9 Billion
- Q1 2025
A detailed history of First Citizens Bank & Trust CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 14,967 shares of DVAX stock, worth $175,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,967Holding current value
$175,862% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$257 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$209 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$91.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$77.1 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.49B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...